305.a Employing functional genomics to decipher clinical impact of suspected patient variants
Prof. Shane T Grey, Australia
305.1 Combining blood gene expression, plasma cellfree DNA, and urine chemokines to diagnose rejection in kidney transplant recipients
Dr. John Friedewald, United States
305.2 Decoding the hallmarks of allograft dysfunction with a comprehensive pan-organ transcriptomic atlas
Mr. Harry L Robertson, Australia
305.3 Using spatial proteomics to explore the alloresponse in abdominal wall and small bowel biopsies
Miss Helen Stark, United Kingdom
305.4 Single-cell RNA sequencing to uncover differential expression genes using peripheral blood mononuclear cells according to rejection types in kidney transplant recipients
Dr. Sung Shin, Korea
305.5 Genetic association in patients undergoing renal allograft transplant: An observational study
Anurag Gupta, India
305.6 Exploring the Molecular Pathways of Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease using Proteomic Analysis
Dr. Jin-Myung Kim, Korea
305.8 Association of donor vascular endothelial growth factor gene polymorphisms with risk of acute kidney allograft rejection